retatrutide pharmacy FDA Approval Status 2026: Everything We Know So Far Demand for Unapproved Weight-Loss Drug
Description
The demographic breakdown shows GLP-1 adoption across income levels, though wealthier populations initially had greater access due to high out-of-pocket costs through traditional pharmacy channels
In the meantime, the new data could still provide guidance to people with diabetes and their doctors, Patell said
Sofwave is cleared by the FDA to: Lift the eyebrows Firm and lift lax tissue on the neck and under the chin Improve the appearance of facial lines and wrinkles Most people see improvement after a single treatment, with results improving for several months as the skin produces new collagen
Cost, gastrointestinal side effects, and insurance access also remain practical barriers for many patients
As a result, nausea and fullness are most pronounced during treatment initiation or dose escalation
